The post states that the branded weekly injection sold for diabetes is approved for type 2 diabetes in adults, while the separately branded weight-management product holds the approval for chronic weight management in adults
Key discussion points for your doctor Screen: BMI criteria, comorbidities, seizure risk, BP control, mood history, opioid use, eating disorders, glaucoma risk Plan: 4week titration
2010 Oct;4(4):466-70
The Biden Administration initially proposed allowing Medicare to cover GLP-1 obesity drugs in Part D, but CMS decided not to proceed with broad weight-loss coverage in early 2025, citing the $40 billion over 10 years projected cost ( [65] ) ( [21] )
How PRF Gel Works The process starts with a simple blood draw
Frequently Asked Questions Will Medi-Cal cover Wegovy if I have type 2 diabetes